Literature DB >> 33456473

Stem Cells in the Treatment of Neuropathic Pain: Research Progress of Mechanism.

Meichen Liu1, Kai Li1, Yunyun Wang1, Guoqing Zhao1, Jinlan Jiang2.   

Abstract

Neuropathic pain (NP) is pain caused by somatosensory nervous system injury or disease. Its prominent symptoms are spontaneous pain, hyperalgesia, and allodynia, and the sense of pain is extremely strong. Owing to the complex mechanism, conventional painkillers lack effectiveness. Recently, research on the treatment of NP by stem cells is increasing and promising results have been achieved in preclinical research. In this review, we briefly introduce the neuropathic pain, the current treatment strategy, and the development of stem cell therapy, and we collected the experimental and clinical trial articles of many kinds of stem cells in the treatment of neuropathic pain from the past ten years. We analyzed and summarized the general efficacy and mechanism of stem cells in the treatment of neuropathic pain. We found that the multiple-mechanism approach was different from the single mechanism of routine clinical drugs; stem cells play a role in peripheral mechanism, central mechanism, and disinhibition of spinal cord level that lead to neuropathic pain, so they are more effective in analgesia and treatment of neuropathic pain.
Copyright © 2020 Meichen Liu et al.

Entities:  

Year:  2020        PMID: 33456473      PMCID: PMC7785341          DOI: 10.1155/2020/8861251

Source DB:  PubMed          Journal:  Stem Cells Int            Impact factor:   5.443


  101 in total

Review 1.  Potential of GABA-ergic cell therapy for schizophrenia, neuropathic pain, and Alzheimer's and Parkinson's diseases.

Authors:  Ashok K Shetty; Adrian Bates
Journal:  Brain Res       Date:  2015-09-28       Impact factor: 3.252

2.  A new definition of neuropathic pain.

Authors:  Troels S Jensen; Ralf Baron; Maija Haanpää; Eija Kalso; John D Loeser; Andrew S C Rice; Rolf-Detlef Treede
Journal:  Pain       Date:  2011-07-18       Impact factor: 6.961

3.  New approach for the treatment of neuropathic pain: Fibroblast growth factor 1 gene-transfected adipose-derived mesenchymal stem cells.

Authors:  F Forouzanfar; B Amin; A Ghorbani; H Ghazavi; F Ghasemi; K Sadri; S Mehri; H R Sadeghnia; H Hosseinzadeh
Journal:  Eur J Pain       Date:  2017-09-26       Impact factor: 3.931

Review 4.  Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment.

Authors:  Ralf Baron; Andreas Binder; Gunnar Wasner
Journal:  Lancet Neurol       Date:  2010-08       Impact factor: 44.182

Review 5.  Etiology and Pharmacology of Neuropathic Pain.

Authors:  Sascha R A Alles; Peter A Smith
Journal:  Pharmacol Rev       Date:  2018-04       Impact factor: 25.468

6.  Demyelination/remyelination and expression of interleukin-1β, substance P, nerve growth factor, and glial-derived neurotrophic factor during trigeminal neuropathic pain in rats.

Authors:  Grazielle Mara Ferreira Costa; Alexandre Penido de Oliveira; Patricia Massara Martinelli; Elizabeth Ribeiro da Silva Camargos; Rosa Maria Esteves Arantes; Camila Megale de Almeida-Leite
Journal:  Neurosci Lett       Date:  2015-12-11       Impact factor: 3.046

Review 7.  GABA and central neuropathic pain following spinal cord injury.

Authors:  Young S Gwak; Claire E Hulsebosch
Journal:  Neuropharmacology       Date:  2011-01-07       Impact factor: 5.250

8.  A single intrathecal injection of GABA permanently reverses neuropathic pain after nerve injury.

Authors:  M J Eaton; M A Martinez; S Karmally
Journal:  Brain Res       Date:  1999-07-24       Impact factor: 3.252

9.  Mesenchymal Stem Cells as Promoters, Enhancers, and Playmakers of the Translational Regenerative Medicine 2018.

Authors:  Andrea Ballini; Stefania Cantore; Salvatore Scacco; Dario Coletti; Marco Tatullo
Journal:  Stem Cells Int       Date:  2018-10-30       Impact factor: 5.443

10.  Intrathecal injection of bone marrow stromal cells attenuates neuropathic pain via inhibition of P2X4R in spinal cord microglia.

Authors:  Yongbo Teng; Yang Zhang; Shouwei Yue; Huanwen Chen; Yujuan Qu; Hui Wei; Xiaofeng Jia
Journal:  J Neuroinflammation       Date:  2019-12-17       Impact factor: 8.322

View more
  7 in total

Review 1.  Modulatory Effects of Stem Cells on Opioid Receptors and Neuroinflammation.

Authors:  Matthew Meroney; Joshua Winegar; Holden Brown; Mark Bender; Scott Smith; Rene Przkora
Journal:  Curr Pain Headache Rep       Date:  2022-02-05

Review 2.  Recent advances in nanoplatforms for the treatment of neuropathic pain.

Authors:  Beibei Yu; Kunzhe Wu; Xiaohua Xu; Yan Liu; Jinlan Jiang
Journal:  Spinal Cord       Date:  2022-01-27       Impact factor: 2.473

3.  Long-Term Effects of Neural Precursor Cell Transplantation on Secondary Injury Processes and Functional Recovery after Severe Cervical Contusion-Compression Spinal Cord Injury.

Authors:  Alexander Younsi; Guoli Zheng; Lennart Riemann; Moritz Scherer; Hao Zhang; Mohamed Tail; Maryam Hatami; Thomas Skutella; Andreas Unterberg; Klaus Zweckberger
Journal:  Int J Mol Sci       Date:  2021-12-03       Impact factor: 5.923

Review 4.  Emerging roles of circular RNAs in neuropathic pain.

Authors:  Derong Xu; Xuexiao Ma; Chong Sun; Jialuo Han; Chuanli Zhou; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2021-10-08       Impact factor: 6.831

5.  Mesenchymal stem cell spheroids alleviate neuropathic pain by modulating chronic inflammatory response genes.

Authors:  Nayeon Lee; Gyu Tae Park; Jae Kyung Lim; Eun Bae Choi; Hye Ji Moon; Dae Kyoung Kim; Seong Min Choi; Young Cheol Song; Tae Kyun Kim; Jae Ho Kim
Journal:  Front Immunol       Date:  2022-08-08       Impact factor: 8.786

6.  SIRT3-Mediated CypD-K166 Deacetylation Alleviates Neuropathic Pain by Improving Mitochondrial Dysfunction and Inhibiting Oxidative Stress.

Authors:  Binbin Yan; Qiang Liu; Xiaobao Ding; Yuwen Lin; Xiaowei Jiao; Yuqing Wu; Huihui Miao; Chenghua Zhou
Journal:  Oxid Med Cell Longev       Date:  2022-09-01       Impact factor: 7.310

Review 7.  Stem Cell Therapy for Modulating Neuroinflammation in Neuropathic Pain.

Authors:  Hari Prasad Joshi; Hyun-Jung Jo; Yong-Ho Kim; Seong-Bae An; Chul-Kyu Park; Inbo Han
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.